Purchase Short-Term Access
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
Tejas V. Patel, MD, MPH, FACP, FASN
Annals of Internal Medicine 2010;152:JC3-9.
doi:10.7326/0003-4819-152-6-201003160-02009
Purchase Online access to this article for 24 hours
